Literature DB >> 3092931

Modern management of non-Hodgkin's lymphoma.

G M Mead, J M Whitehouse.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3092931      PMCID： PMC1341374          DOI： 10.1136/bmj.293.6547.577

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  34 in total

1.  Composite lymphoma.

Authors:  H Kim; R Hendrickson; R F Dorfman
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

2.  Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.

Authors:  S Monfardini; A Banfi; G Bonadonna; F Rilke; F Milani; P Valagussa; A Lattuada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-02       Impact factor: 7.038

3.  Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma.

Authors:  L F Cohen; J E Balow; I T Magrath; D G Poplack; J L Ziegler
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

4.  The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation.

Authors:  R T Hoppe; P Kushlan; H S Kaplan; S A Rosenberg; B W Brown
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

5.  Late relapse from complete remission in nodular and diffuse histiocytic lymphoma.

Authors:  G M Mead; F R Mackintosh; J S Burke; S A Rosenberg
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

6.  Lymphoblastic lymphoma in adults.

Authors:  D E Slater; R Mertelsmann; B Koziner; C Higgins; S McKenzie; P Schauer; T Gee; D Straus; S Kempin; Z Arlin
Journal:  J Clin Oncol       Date:  1986-01       Impact factor: 44.544

7.  Primary extranodal lymphoma: response to treatment and factors influencing prognosis.

Authors:  R A Rudders; M E Ross; R A DeLellis
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

8.  Initial chemotherapy for clinically localized lymphomas of unfavorable histology.

Authors:  T P Miller; S E Jones
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

9.  Intestinal lymphoma associated with malabsorption.

Authors:  P Isaacson; D H Wright
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

10.  Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces.

Authors:  T J Hamblin; A K Abdul-Ahad; J Gordon; F K Stevenson; G T Stevenson
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640
View more
  3 in total

1.  Long term survival after treatment of disseminated T cell lymphoma presenting with tracheal obstruction in a patient with coeliac disease.

Authors:  D J Seddon; K F Chung; F J Paradinas; E S Newlands; P D Snashall
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

2.  Prognostic indicators in centroblastic-centrocytic lymphoma.

Authors:  N R Griffin; M R Howard; P Quirke; C J O'Brien; J A Child; C C Bird
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

3.  Primary B cell malignant lymphoma of the trachea.

Authors:  J Wiggins; E Sheffield; M Green
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.